VOLUNTARY ANNOUNCEMENT COLLABORATION AGREEMENT WITH ASCENTAGE PHARMACollaboration Agreement • April 21st, 2021
Contract Type FiledApril 21st, 2021This announcement is made by the board of directors (the “Board”) of Clover Biopharmaceuticals, Ltd. (the “Company”, together with its subsidiaries, the “Group”) on a voluntary basis to inform the shareholders of the Company and potential investors on the latest business development of the Group.